Aurinia Pharm Ord (AUPH)

$8.63 +0.60 (7.47%)
Market Cap 1.09B
Revenue (ttm) 235.13M
Net Income (ttm) 5.75M
EPS (ttm) N/A
PE Ratio 21.16
Forward PE 13.27
Profit Margin 2.45%
Debt to Equity Ratio 0.00
Volume 3,510,250
Avg Vol 1,157,922
Day's Range N/A - N/A
Shares Out 135.10M
Stochastic %K 53%
Beta 1.15
Analysts Strong Sell
Price Target $10.00

Company Profile

Aurinia Pharmaceuticals Inc. is a biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs. It offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. The company also develops AUR200, a dual inhibitor of B cell activating factor and a proliferation inducing ligand for the potential treatment of autoimmune diseases. It has a collaboration and license agreement wit...

Industry: Biotechnology
Sector: Healthcare
Phone: 250 744 2487
Fax: 250 708 4345
Address:
#140, 14315 – 118 Avenue, Edmonton, Canada
Ttubular
Ttubular Jun. 26 at 8:33 PM
$AUPH back to $8PIN tomorrow?
0 · Reply
Ruffy__
Ruffy__ Jun. 26 at 8:32 PM
$AUPH
0 · Reply
RicardoDelJuego
RicardoDelJuego Jun. 26 at 8:31 PM
$AUPH 2nd highest closing share price of the year, and 3rd highest volume of the year.
0 · Reply
starkist
starkist Jun. 26 at 8:28 PM
$AUPH i am quietly hoping the news is not coming from aurinia!
0 · Reply
Mooch99
Mooch99 Jun. 26 at 8:24 PM
$AUPH Awesome day. This seems constructive.
0 · Reply
ChuckBarrisJr
ChuckBarrisJr Jun. 26 at 8:16 PM
$AUPH OK, so what’s the news? The volume says we have news coming.
0 · Reply
michalinho
michalinho Jun. 26 at 8:04 PM
$AUPH and now?🙈🎈
4 · Reply
JBRUN
JBRUN Jun. 26 at 8:01 PM
$AUPH closing volume 3.51M
1 · Reply
VAsooner
VAsooner Jun. 26 at 7:55 PM
$AUPH Get your shares before the Halt !!
0 · Reply
biiktor
biiktor Jun. 26 at 7:43 PM
$AUPH Halt AH! come on PiG.
0 · Reply
Latest News on AUPH
New AURORA 1 Analysis: LUPKYNIS-Based Triple Immunosuppressive Therapy Yields Deep Proteinuria Reduction in Lupus Nephritis

May 22, 2025, 6:00 AM EDT - 5 weeks ago

New AURORA 1 Analysis: LUPKYNIS-Based Triple Immunosuppressive Therapy Yields Deep Proteinuria Reduction in Lupus Nephritis

Aurinia Pharma Swings Into Profit As Q1 Sales Jumps 24%, Sticks To Guidance

May 12, 2025, 12:56 PM EDT - 6 weeks ago

Aurinia Pharma Swings Into Profit As Q1 Sales Jumps 24%, Sticks To Guidance

Aurinia Pharmaceuticals Inc. (AUPH) Q1 2025 Earnings Call Transcript

May 12, 2025, 11:04 AM EDT - 6 weeks ago

Aurinia Pharmaceuticals Inc. (AUPH) Q1 2025 Earnings Call Transcript

Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025

May 12, 2025, 6:00 AM EDT - 6 weeks ago

Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025

Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025

May 5, 2025, 6:00 AM EDT - 7 weeks ago

Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025

Glass Lewis Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting

Apr 30, 2025, 6:00 AM EDT - 2 months ago

Glass Lewis Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting

ISS Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting

Apr 29, 2025, 6:00 AM EDT - 2 months ago

ISS Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting

Aurinia Pharmaceuticals: Shareholder Pressure And Sales Growth

Apr 26, 2025, 10:54 AM EDT - 2 months ago

Aurinia Pharmaceuticals: Shareholder Pressure And Sales Growth

Concerned Shareholders of Aurinia Pharmaceuticals Announce Their Intention to Withhold Support for CEO Peter Greenleaf at 2025 Annual Meeting

Apr 23, 2025, 4:05 PM EDT - 2 months ago

Concerned Shareholders of Aurinia Pharmaceuticals Announce Their Intention to Withhold Support for CEO Peter Greenleaf at 2025 Annual Meeting

Autoimmune Disease-Focused Aurinia Pharmaceuticals Reports Quarterly Profit, Revenue Outlook Below Expectations

Feb 27, 2025, 2:11 PM EST - 4 months ago

Autoimmune Disease-Focused Aurinia Pharmaceuticals Reports Quarterly Profit, Revenue Outlook Below Expectations

Aurinia Pharmaceuticals Inc. (AUPH) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 10:32 AM EST - 4 months ago

Aurinia Pharmaceuticals Inc. (AUPH) Q4 2024 Earnings Call Transcript

Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Update on Recent Corporate Progress

Feb 27, 2025, 6:00 AM EST - 4 months ago

Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Update on Recent Corporate Progress

Aurinia Pharmaceuticals: There's Still Time For Sales Growth

Feb 21, 2025, 4:09 PM EST - 4 months ago

Aurinia Pharmaceuticals: There's Still Time For Sales Growth

Aurinia Pharmaceuticals to Release 2024 Fourth Quarter and Full Year Financial and Operational Results on February 27, 2025

Feb 20, 2025, 4:05 PM EST - 4 months ago

Aurinia Pharmaceuticals to Release 2024 Fourth Quarter and Full Year Financial and Operational Results on February 27, 2025

3 Biotech Stocks With Notable Insider Buying

Jan 22, 2025, 12:29 PM EST - 5 months ago

3 Biotech Stocks With Notable Insider Buying

AZN COGT JAZZ ONC XBI ZYME

Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis

Nov 18, 2024, 5:53 PM EST - 7 months ago

Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis

Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of LUPKYNIS® in Managing LN at American College of Rheumatology Convergence 2024

Nov 15, 2024, 6:00 AM EST - 7 months ago

Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of LUPKYNIS® in Managing LN at American College of Rheumatology Convergence 2024

Aurinia to Participate in Jefferies London Healthcare Conference

Nov 14, 2024, 6:00 AM EST - 8 months ago

Aurinia to Participate in Jefferies London Healthcare Conference

Aurinia Pharmaceuticals: A Potential Buyout Looms On The Horizon

Nov 8, 2024, 12:15 PM EST - 8 months ago

Aurinia Pharmaceuticals: A Potential Buyout Looms On The Horizon

Aurinia Pharmaceuticals, Inc. (AUPH) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 11:44 AM EST - 8 months ago

Aurinia Pharmaceuticals, Inc. (AUPH) Q3 2024 Earnings Call Transcript

Aurinia Pharmaceuticals Appoints Craig Johnson to Board of Directors to Support Next Phase of Growth

Nov 7, 2024, 6:10 AM EST - 8 months ago

Aurinia Pharmaceuticals Appoints Craig Johnson to Board of Directors to Support Next Phase of Growth

Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS® Growth and AUR200 Development

Nov 7, 2024, 6:00 AM EST - 8 months ago

Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS® Growth and AUR200 Development

Aurinia Pharmaceuticals to Release Third Quarter Financial and Operational Results on November 7, 2024

Oct 30, 2024, 4:05 PM EDT - 8 months ago

Aurinia Pharmaceuticals to Release Third Quarter Financial and Operational Results on November 7, 2024

Aurinia Presents New Data Highlighting Real-World Utilization and Value of LUPKYNIS® in Treating Lupus Nephritis at American Society of Nephrology Kidney Week 2024

Oct 11, 2024, 6:00 AM EDT - 9 months ago

Aurinia Presents New Data Highlighting Real-World Utilization and Value of LUPKYNIS® in Treating Lupus Nephritis at American Society of Nephrology Kidney Week 2024

Aurinia Announces Japan Approval of LUPKYNIS® (Voclosporin) to Treat Lupus Nephritis

Sep 24, 2024, 8:10 AM EDT - 9 months ago

Aurinia Announces Japan Approval of LUPKYNIS® (Voclosporin) to Treat Lupus Nephritis

3 Small Biotech Stocks With The 'Big Mo' Right Now

Sep 19, 2024, 12:54 PM EDT - 10 months ago

3 Small Biotech Stocks With The 'Big Mo' Right Now

CORT VRDN

Aurinia Pharmaceuticals: LUPKYNIS Leading The Way In Lupus Nephritis Treatment

Sep 19, 2024, 7:55 AM EDT - 10 months ago

Aurinia Pharmaceuticals: LUPKYNIS Leading The Way In Lupus Nephritis Treatment

Aurinia Pharmaceuticals: This Recovery Can Continue

Sep 18, 2024, 4:41 AM EDT - 10 months ago

Aurinia Pharmaceuticals: This Recovery Can Continue

Aurinia to Participate in 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 13, 2024, 6:00 AM EDT - 10 months ago

Aurinia to Participate in 2024 Cantor Fitzgerald Global Healthcare Conference

Aurinia Announces Board Restructuring

Sep 12, 2024, 4:05 PM EDT - 10 months ago

Aurinia Announces Board Restructuring

Aurinia Announces First Participant Dosed in AUR200 Single Ascending Dose Trial

Sep 5, 2024, 6:00 AM EDT - 10 months ago

Aurinia Announces First Participant Dosed in AUR200 Single Ascending Dose Trial

Aurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Aug 28, 2024, 6:00 AM EDT - 10 months ago

Aurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Aurinia Pharmaceuticals Shareholder Calls for CEO Peter Greenleaf, Dr. Brinda Balakrishnan, and Dr. Robert Foster to Resign from the Board

Aug 13, 2024, 8:00 AM EDT - 11 months ago

Aurinia Pharmaceuticals Shareholder Calls for CEO Peter Greenleaf, Dr. Brinda Balakrishnan, and Dr. Robert Foster to Resign from the Board

Aurinia Pharmaceuticals, Inc. (AUPH) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 1:52 PM EDT - 11 months ago

Aurinia Pharmaceuticals, Inc. (AUPH) Q2 2024 Earnings Call Transcript

Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2024 Financial and Operational Results

Aug 1, 2024, 6:00 AM EDT - 11 months ago

Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2024 Financial and Operational Results

Aurinia Pharmaceuticals to Release Second Quarter Financial and Operational Results on August 1, 2024

Jul 19, 2024, 6:00 AM EDT - 1 year ago

Aurinia Pharmaceuticals to Release Second Quarter Financial and Operational Results on August 1, 2024

ILJIN SNT Co., Ltd. Calls on Board of Aurinia Pharmaceuticals to Honor Shareholders' Voices Expressed at the AGM

Jul 11, 2024, 3:27 PM EDT - 1 year ago

ILJIN SNT Co., Ltd. Calls on Board of Aurinia Pharmaceuticals to Honor Shareholders' Voices Expressed at the AGM

Aurinia Pharmaceuticals Appears Undervalued

Jul 5, 2024, 2:10 PM EDT - 1 year ago

Aurinia Pharmaceuticals Appears Undervalued

Aurinia to Participate in Upcoming Investor Healthcare Conferences

Jul 2, 2024, 6:00 AM EDT - 1 year ago

Aurinia to Participate in Upcoming Investor Healthcare Conferences

Aurinia Announces 2024 Annual General Meeting Results

Jun 14, 2024, 12:16 PM EDT - 1 year ago

Aurinia Announces 2024 Annual General Meeting Results

Aurinia Presents Safety and Efficacy Profile of LUPKYNIS® for People with Lupus Nephritis at European Alliance of Associations for Rheumatology (EULAR) Congress 2024

Jun 5, 2024, 6:00 AM EDT - 1 year ago

Aurinia Presents Safety and Efficacy Profile of LUPKYNIS® for People with Lupus Nephritis at European Alliance of Associations for Rheumatology (EULAR) Congress 2024

Aurinia Addresses Dubious Proposals Put Forth by Lucien Selce

Jun 4, 2024, 5:30 PM EDT - 1 year ago

Aurinia Addresses Dubious Proposals Put Forth by Lucien Selce

Aurinia Provides Update on Proxy Statement

Jun 3, 2024, 6:30 PM EDT - 1 year ago

Aurinia Provides Update on Proxy Statement

Aurinia Pharmaceuticals Shareholder Urges Fellow Shareholders to Withhold Support for CEO Peter Greenleaf

Jun 3, 2024, 8:00 AM EDT - 1 year ago

Aurinia Pharmaceuticals Shareholder Urges Fellow Shareholders to Withhold Support for CEO Peter Greenleaf

3 Biotech Names Under $10 I Own

Jun 2, 2024, 10:18 AM EDT - 1 year ago

3 Biotech Names Under $10 I Own

FOLD VYGR

Aurinia Will Attend 2024 Jefferies Global Healthcare Conference

May 30, 2024, 6:00 AM EDT - 1 year ago

Aurinia Will Attend 2024 Jefferies Global Healthcare Conference

Analysis Showing LUPKYNIS® is a Cost-Effective Treatment for Lupus Nephritis Presented at National Kidney Foundation's Spring Clinical Meeting 2024

May 14, 2024, 6:00 AM EDT - 1 year ago

Analysis Showing LUPKYNIS® is a Cost-Effective Treatment for Lupus Nephritis Presented at National Kidney Foundation's Spring Clinical Meeting 2024

Aurinia Presents Data Reinforcing LUPKYNIS® Safety and Efficacy for People with Lupus Nephritis at Congress of Clinical Rheumatology East 2024

May 9, 2024, 6:00 AM EDT - 1 year ago

Aurinia Presents Data Reinforcing LUPKYNIS® Safety and Efficacy for People with Lupus Nephritis at Congress of Clinical Rheumatology East 2024

Aurinia Pharmaceuticals Shareholder Urges Board of Directors to Take Action to Enhance Shareholder Value

May 7, 2024, 9:00 AM EDT - 1 year ago

Aurinia Pharmaceuticals Shareholder Urges Board of Directors to Take Action to Enhance Shareholder Value

Aurinia Will Attend 2024 RBC Capital Markets Global Healthcare Conference

May 7, 2024, 6:00 AM EDT - 1 year ago

Aurinia Will Attend 2024 RBC Capital Markets Global Healthcare Conference

Ttubular
Ttubular Jun. 26 at 8:33 PM
$AUPH back to $8PIN tomorrow?
0 · Reply
Ruffy__
Ruffy__ Jun. 26 at 8:32 PM
$AUPH
0 · Reply
RicardoDelJuego
RicardoDelJuego Jun. 26 at 8:31 PM
$AUPH 2nd highest closing share price of the year, and 3rd highest volume of the year.
0 · Reply
starkist
starkist Jun. 26 at 8:28 PM
$AUPH i am quietly hoping the news is not coming from aurinia!
0 · Reply
Mooch99
Mooch99 Jun. 26 at 8:24 PM
$AUPH Awesome day. This seems constructive.
0 · Reply
ChuckBarrisJr
ChuckBarrisJr Jun. 26 at 8:16 PM
$AUPH OK, so what’s the news? The volume says we have news coming.
0 · Reply
michalinho
michalinho Jun. 26 at 8:04 PM
$AUPH and now?🙈🎈
4 · Reply
JBRUN
JBRUN Jun. 26 at 8:01 PM
$AUPH closing volume 3.51M
1 · Reply
VAsooner
VAsooner Jun. 26 at 7:55 PM
$AUPH Get your shares before the Halt !!
0 · Reply
biiktor
biiktor Jun. 26 at 7:43 PM
$AUPH Halt AH! come on PiG.
0 · Reply
SCCT2FL
SCCT2FL Jun. 26 at 7:27 PM
$AUPH Peter is finally going to tell us what the circumstances were for him not leaving after being voted off the island 🤣🤣
0 · Reply
Yarrow
Yarrow Jun. 26 at 7:26 PM
$AUPH why is this up 7 percent? Huh.
2 · Reply
dabigkez
dabigkez Jun. 26 at 7:22 PM
$AUPH been here since phase 2 so learned to not get excited but am I the only one to expect aur200 to be a nothing burger? Unless deaths (which god willing not) you expect it to move forward. Believe someone posted job ad last week that amplifies the phase 2. I dunno I just can’t see this moving needle or else this wouldn’t have been scrapped yr plus ago
0 · Reply
sck2
sck2 Jun. 26 at 7:19 PM
$AUPH it would of been nice to see us go over $9 today the rest of the market is on fire and should of carried us to $9+ ... ?
1 · Reply
Auphiliate
Auphiliate Jun. 26 at 7:09 PM
$AUPH Spoke with my pharma son today. He is a sales rep and said if he were selling Lupkynis he would have no difficulty due to its first line and oral med status. He became fed up with management who he thinks were just too self serving and lazy to market the drug, so sold his shares last year and went into bitcoin! 🤷‍♀️
1 · Reply
Trade_and_Profit
Trade_and_Profit Jun. 26 at 7:04 PM
$AUPH the end of June news prediction AUR200, release the Kraken greedy Pete investors deserve to see some value since you have high jacked our company to use as your personal piggy bank.
0 · Reply
BioCrazy1
BioCrazy1 Jun. 26 at 6:57 PM
$AUPH
0 · Reply
jdoldnumber7
jdoldnumber7 Jun. 26 at 6:50 PM
$AUPH Let's see how she finishes the day. I like to think we get solid news after hours or tomorrow. Since tomorrow is Friday, FOMO will be in play if news is delayed until Monday.
0 · Reply
Freetimeod
Freetimeod Jun. 26 at 6:11 PM
$AUPH the “Little Dick” is buying shares with your money again? Still a long way from his BE on options, $12.
0 · Reply
joemist1
joemist1 Jun. 26 at 6:09 PM
$AUPH Did tang finish buying the whole company up yet? What’s taking too long?
0 · Reply
petersadick
petersadick Jun. 26 at 6:01 PM
$AUPH here comes the afternoon peterplunge
1 · Reply
Jcljack26
Jcljack26 Jun. 26 at 5:54 PM
$AUPH First one to break the news gets $1.
1 · Reply